Author:

Keywords:

Cardiomyopathy, Congenital heart disease, Heart failure, Pulmonary hypertension, Stress echocardiography, Stress test, Valvular heart disease, Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Radiology, Nuclear Medicine & Medical Imaging, Cardiovascular System & Cardiology, VENTRICULAR CONTRACTILE RESERVE, GRADIENT AORTIC-STENOSIS, EXERCISE-INDUCED CHANGES, PULMONARY ARTERIAL-HYPERTENSION, CARDIAC RESYNCHRONIZATION THERAPY, FUNCTIONAL MITRAL REGURGITATION, IDIOPATHIC DILATED CARDIOMYOPATHY, EMISSION COMPUTED-TOMOGRAPHY, OUTFLOW TRACT OBSTRUCTION, ULTRASOUND LUNG COMETS, American Heart Association, Cardiac Imaging Techniques, Cardiomyopathy, Hypertrophic, Coronary Artery Disease, Echocardiography, Stress, Echocardiography, Three-Dimensional, Europe, Female, Humans, Male, Myocardial Ischemia, Practice Guidelines as Topic, Sensitivity and Specificity, Societies, Medical, United States, 3201 Cardiovascular medicine and haematology

Abstract:

A unique and highly versatile technique, stress echocardiography (SE) is increasingly recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for simultaneous assessment of myocardial function and haemodynamics under physiological or pharmacological conditions. Due to its diagnostic and prognostic value, SE has become widely implemented to assess various conditions other than ischaemic heart disease. It has thus become essential to establish guidance for its applications and performance in the area of non-ischaemic heart disease. This paper summarizes these recommendations.